drugset / Trial / NCT02303639

Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Ischemic Ventricular Tachyarrhythmias

NCT02303639

RandomizedParallel-groupOpen-labelTreatment

Summary

The study evaluates whether catheter based radiofrequency ablation is superior to optimized antiarrhythmic medical therapy in preventing ventricular tachyarrhythmia relapses in patients with ischemic heart disease and implantable cardioverter defibrillator.

Timeline

Start
2015-04
Primary completion
2017-06
Completion
2018-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amiodarone Small molecule Oral
Comparator sotalol Small molecule Oral